Skip to main content

WELLS FARGO & COMPANY/MN

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in XERS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,247,295
+$909,116 QoQ
Shares Held
157,487
+170.1% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 238 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XERS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $472,275,691 across 58 Drug Manufacturers - Specialty & Generic names. XERS ranks #29 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in XERS

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,247,295 157,487
2026-03-31 $338,179 58,307
2025-12-31 $1,340,748 170,796
2025-09-30 $791,175 97,196
2025-06-30 $375,309 80,366
2025-03-31 $383,645 69,881
2024-12-31 $267,931 79,036
2024-09-30 $162,409 56,986
2024-06-30 $134,218 59,653
2024-03-31 $115,459 52,244
2023-12-31 $105,378 44,842
2023-09-30 $68,798 36,989
2023-06-30 $172,628 65,889
2023-03-31 $58,577 35,937
2022-12-31 $14,780 11,113
2022-09-30 $21,150 13,558
2022-06-30 $22,710 14,747
2022-03-31 $28,449 11,113
2021-12-31 $34,219 11,679